Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-02 09:57 am Purchase |
2024-11-12 | 13G | NeurAxis, Inc. NRXS |
Rosalind Advisors Inc. | 2,100,840 9.900% |
2,100,840 (New Position) |
Filing History |
| 2024-11-15 10:33 am Unchanged |
2024-10-30 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 2,763,468 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-14 9:46 pm Unchanged |
2024-10-30 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 2,763,468 9.900% |
0 (Unchanged) |
Filing History |
| 2024-11-06 10:48 am Sale |
2024-10-31 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors Inc. | 7,196,776 6.900% |
-675,713 (-8.58%) |
Filing History |
| 2024-10-28 4:02 pm Unchanged |
2024-09-30 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 7,438,181 9.800% |
0 (Unchanged) |
Filing History |
| 2024-10-23 3:14 pm Unchanged |
2024-09-30 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors Inc. | 7,872,489 8.900% |
0 (Unchanged) |
Filing History |
| 2024-10-23 3:05 pm Unchanged |
2024-09-30 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors Inc. | 686,172 9.900% |
0 (Unchanged) |
Filing History |
| 2024-10-23 2:57 pm Purchase |
2024-09-30 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors Inc. | 628,050 5.800% |
114,560 (+22.31%) |
Filing History |
| 2024-10-23 2:44 pm Sale |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors Inc. | 750,000 1.030% |
-641,577 (-46.10%) |
Filing History |
| 2024-10-23 2:26 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors Inc. | 0 0.000% |
-1,508,419 (Position Closed) |
Filing History |
| 2024-10-18 2:52 pm Purchase |
2024-09-30 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors Inc. | 552,500 5.500% |
49,357 (+9.81%) |
Filing History |
| 2024-10-18 2:21 pm Unchanged |
2024-09-30 | 13G | Myomo, Inc. MYO |
Rosalind Advisors Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-08-14 7:20 pm Purchase |
2024-08-06 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors Inc. | 686,172 9.900% |
686,172 (New Position) |
Filing History |
| 2024-08-14 7:15 pm Purchase |
2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 232,348 9.900% |
99,261 (+74.58%) |
Filing History |
| 2024-07-12 10:35 am Unchanged |
2024-06-28 | 13G | Myomo, Inc. MYO |
Rosalind Advisors Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-07-11 6:02 pm Unchanged |
2024-06-28 | 13G | Myomo, Inc. MYO |
Rosalind Advisors Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-07-11 5:52 pm Purchase |
2024-06-28 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors Inc. | 1,391,577 1.980% |
465,561 (+50.28%) |
Filing History |
| 2024-07-11 5:48 pm Sale |
2024-06-28 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors Inc. | 7,438,181 9.900% |
-21,747 (-0.29%) |
Filing History |
| 2024-07-11 5:43 pm Purchase |
2024-06-28 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors Inc. | 513,490 7.160% |
27,500 (+5.66%) |
Filing History |
| 2024-07-11 5:37 pm Unchanged |
2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 133,086 9.900% |
0 (Unchanged) |
Filing History |